Skip to content

Clinical reevaluation of Kangshuailao tablet: A clinical study on the attenuation and synergistic effect of Kangshuailao tablet adjuvant chemotherapy for lung cancer

The clinical study on the attenuation and synergistic effect of Kangshuailao tablet adjuvant chemotherapy for lung cancer

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-16007802
Enrollment
Unknown
Registered
2016-01-18
Start date
2016-01-18
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer (qi and yin deficiency syndrome)

Interventions

Treatment group:Conventional chemotherapy + Kangshuailao tablet

Sponsors

Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Aged 18 to 75 years; (2) Corresponding to the diagnostic criteria of non small cell lung cancer; (3) Corresponding to TCM syndrome diagnosis of Qi Yin deficiency; (4) Physical status score (Karnofsky Performance Status, KPS) is more than 70 and the survival time is expected to be more than 3 months; (5) The various indexes were examined are indications of chemotherapy; (6) There is no history of radiotherapy and chemotherapy among one month before treatment; (7) The patients voluntarily accept the medical treatment and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Pregnancy, lactation women, mental patients; (2) Serious heart, liver or renal disease, or there are significant anomaly in blood, hepatorenal function; (3) History of drug allergy; (4) Poor compliance.

Design outcomes

Primary

MeasureTime frame
Bone marrow suppression;

Secondary

MeasureTime frame
TCM symptom score;Immunologic function;EORTC QLQ-C30;EORTC QLQ-LC13;

Countries

China

Contacts

Public ContactHongbo Cao
caohongboebm@foxmail.com+86 13752330880

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026